Sustained Remission After Treatment with Rituximab in CIDP Without Nodal/Paranodal Antibodies
Study Overview The investigation into the efficacy of Rituximab in chronic inflammatory demyelinating polyneuropathy (CIDP) without nodal or paranodal antibodies […]
